Purdue Pharma has won support from the attorneys general of 55 U.S. states and territories for its $7.4 billion settlement to ...

NEW YORK, Oct 31 (Reuters) - Purdue Pharma is close to a new bankruptcy settlement with its owners, members of the wealthy Sackler family, and state and local governments that have filed lawsuits ...

NEW YORK- Purdue Pharma has won support from the attorneys general of 55 U.S. states and territories for its $7.4 billion settlement to resolve thousands of opioid lawsuits against the drugmaker ...

Purdue Pharma has filed a new bankruptcy plan that will distribute more than $7.4 billion to compensate opioid epidemic victims and fund addiction treatment programs.

The billionaire family that owns Purdue Pharma, maker of the pain medication blamed for helping fuel the nation’s opioid crisis, has agreed to increase payments to settle long-running litigation ...

A new $7.4 billion opioid settlement for Purdue Pharma and the Sackler family has been approved by all U.S. states and territories ...

Purdue Pharma LP has filed a new Chapter 11 plan with the US Bankruptcy Court for the Southern District of New York, pledging it will give creditors including US states and other parties more than ...

New York State officials said they are prepared to resume litigation against Purdue Pharma and the Sackler family should the parties fail to agree by a Sept. 9 court-imposed deadline on a ...

In 2019, New York State Attorney General Letitia James announced a lawsuit against the Sackler family and Purdue Pharma. Over five years later, a $7.4 billion settlement appears poised for final ...

Purdue Pharma has filed a new bankruptcy plan as part of a $7.4 billion settlement resolving lawsuits over its alleged role in the opioid crisis, months after the Supreme Court blocked a prior deal.

Purdue Pharma owners strike new $6.5 billion deal in opioid case The deal comes after the Supreme Court blocked a controversial bankruptcy plan for Purdue that shielded Sackler family members from ...